Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
333 | 3 | P53//RETINOBLASTOMA//MDM2 | 37839 |
454 | 2 | CELL CYCLE//CYCLIN DEPENDENT KINASE//E2F | 16304 |
6013 | 1 | FLAVOPIRIDOL//PALBOCICLIB//CYCLIN DEPENDENT KINASE | 1574 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | FLAVOPIRIDOL | authKW | 1227261 | 7% | 54% | 114 |
2 | PALBOCICLIB | authKW | 796132 | 3% | 76% | 52 |
3 | CYCLIN DEPENDENT KINASE | authKW | 545667 | 11% | 15% | 179 |
4 | ROSCOVITINE | authKW | 474728 | 5% | 31% | 77 |
5 | CELL CYCLE REGULAT GRP | address | 369991 | 2% | 60% | 31 |
6 | CDK INHIBITOR | authKW | 317923 | 5% | 20% | 78 |
7 | RIBOCICLIB | authKW | 301501 | 1% | 94% | 16 |
8 | CDK4 6 | authKW | 289104 | 1% | 76% | 19 |
9 | CDK4 6 INHIBITOR | authKW | 276149 | 1% | 69% | 20 |
10 | ABEMACICLIB | authKW | 275530 | 1% | 81% | 17 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 8168 | 38% | 0% | 598 |
2 | Chemistry, Medicinal | 4737 | 17% | 0% | 263 |
3 | Cell Biology | 1384 | 17% | 0% | 263 |
4 | Pharmacology & Pharmacy | 859 | 16% | 0% | 248 |
5 | Biochemistry & Molecular Biology | 593 | 20% | 0% | 312 |
6 | Hematology | 344 | 5% | 0% | 83 |
7 | Chemistry, Organic | 259 | 7% | 0% | 116 |
8 | Biophysics | 71 | 4% | 0% | 56 |
9 | Computer Science, Interdisciplinary Applications | 51 | 2% | 0% | 35 |
10 | Medicine, Research & Experimental | 36 | 3% | 0% | 48 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CELL CYCLE REGULAT GRP | 369991 | 2% | 60% | 31 |
2 | DTP CLIN TRIALS UNIT | 122631 | 0% | 88% | 7 |
3 | MOL THER EUT UNIT | 73398 | 1% | 33% | 11 |
4 | GROWTH REGULATORS | 69261 | 3% | 8% | 44 |
5 | EARNEST ORLANDO BERKELEY | 40043 | 0% | 100% | 2 |
6 | MED 1COMPREHENS CANC | 40043 | 0% | 100% | 2 |
7 | HOTEL RECH | 35590 | 0% | 44% | 4 |
8 | PROT PHOSPHORYLAT HUMAN DIS GRP | 30018 | 1% | 17% | 9 |
9 | BUSINESS UNIT ONCOL | 27713 | 0% | 23% | 6 |
10 | BIOL STN | 24010 | 3% | 3% | 42 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MOLECULAR CANCER THERAPEUTICS | 11382 | 3% | 1% | 49 |
2 | CLINICAL CANCER RESEARCH | 6331 | 4% | 0% | 70 |
3 | CELL CYCLE | 4289 | 2% | 1% | 29 |
4 | COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY SERIES | 3521 | 1% | 1% | 18 |
5 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 3089 | 4% | 0% | 64 |
6 | JOURNAL OF MEDICINAL CHEMISTRY | 3004 | 4% | 0% | 58 |
7 | CANCER CELL | 1796 | 1% | 1% | 12 |
8 | EXPERT OPINION ON INVESTIGATIONAL DRUGS | 1739 | 1% | 1% | 14 |
9 | INVESTIGATIONAL NEW DRUGS | 1710 | 1% | 1% | 15 |
10 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1499 | 2% | 0% | 24 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FLAVOPIRIDOL | 1227261 | 7% | 54% | 114 | Search FLAVOPIRIDOL | Search FLAVOPIRIDOL |
2 | PALBOCICLIB | 796132 | 3% | 76% | 52 | Search PALBOCICLIB | Search PALBOCICLIB |
3 | CYCLIN DEPENDENT KINASE | 545667 | 11% | 15% | 179 | Search CYCLIN+DEPENDENT+KINASE | Search CYCLIN+DEPENDENT+KINASE |
4 | ROSCOVITINE | 474728 | 5% | 31% | 77 | Search ROSCOVITINE | Search ROSCOVITINE |
5 | CDK INHIBITOR | 317923 | 5% | 20% | 78 | Search CDK+INHIBITOR | Search CDK+INHIBITOR |
6 | RIBOCICLIB | 301501 | 1% | 94% | 16 | Search RIBOCICLIB | Search RIBOCICLIB |
7 | CDK4 6 | 289104 | 1% | 76% | 19 | Search CDK4+6 | Search CDK4+6 |
8 | CDK4 6 INHIBITOR | 276149 | 1% | 69% | 20 | Search CDK4+6+INHIBITOR | Search CDK4+6+INHIBITOR |
9 | ABEMACICLIB | 275530 | 1% | 81% | 17 | Search ABEMACICLIB | Search ABEMACICLIB |
10 | DINACICLIB | 269761 | 1% | 84% | 16 | Search DINACICLIB | Search DINACICLIB |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |
rank | cluster_id2 | link |
---|---|---|
1 | 26026 | CAK//CDK ACTIVATING KINASE//CDKN3 |
2 | 26920 | UCN 01//7 HYDROXYSTAUROSPORINE//CGP41251 |
3 | 34619 | CYCLIN A1//SPY1//SPEEDY |
4 | 3974 | CYCLIN D1//CYCLIN E//CCND1 |
5 | 34749 | FASCAPLYSIN//HOMOFASCAPLYSIN C//PYRIDO1 2 A3 4 B DIINDOLE |
6 | 36739 | CDK11P58//PITSLRE//CDK11 |
7 | 11376 | CDK5//CYCLIN DEPENDENT KINASE 5//P35 |
8 | 35660 | ROHITUKINE//CHROMONE ALKALOIDS//DYSOXYLUM BINECTARIFERUM |
9 | 31806 | PAULLONES//HALOHETEROCYCLIZATION//DARPONES |
10 | 31348 | CYCLIN B1//CCNB1//AGE ASSOCIATED ASPECT |